All intervention and placebo groups received subcutaneous semaglutide 2.4 mg injections once weekly
For most sublingual users, this lands somewhere between 4 and 10 mg daily, though individual variation is significant
During wound healing, it can be removed from existing extracellular proteins by proteolysis and used as a chemical attractant for inflammatory and endothelial cells It can increase the production of messenger RNA in collagen, elastin, proteoglycans and glycosaminoglycans in fibroblasts
For nerve-specific applications, subcutaneous injection near the affected area (when accessible) may offer advantages over distant-site injection, though systemic administration also shows efficacy in the published research
BPC-157 in a rat Achilles tendon model
Also has anti-nausea properties